GOLD SWAP Stock price OTC Bulletin Board
Equities
GDSW
US38074W1009
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Financials (USD)
Sales 2024 * | 72K | Sales 2025 * | 72K | Capitalization | 5.54M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -8M | EV / Sales 2024 * | 77 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 77 x |
P/E ratio 2024 * |
-3.48
x | P/E ratio 2025 * |
-2.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.26% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Weisblum
CEO | Chief Executive Officer | 54 | 10-07-12 |
Daniel Ryweck
DFI | Director of Finance/CFO | 59 | 22-09-26 |
James Kuo
CTO | Chief Tech/Sci/R&D Officer | 58 | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Weisblum
CEO | Chief Executive Officer | 54 | 10-07-12 |
Wayne Linsley
BRD | Director/Board Member | 67 | 20-01-15 |
Kevin Muñoz
BRD | Director/Board Member | 46 | 20-09-30 |
1st Jan change | Capi. | |
---|---|---|
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |
- Stock
- Equities
- Stock Silo Pharma, Inc.
- Stock GOLD SWAP - OTC Bulletin Board